CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 92 filers reported holding CUE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 2.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $58,000 | -56.7% | 26,205 | -51.4% | 0.00% | – |
| Q2 2022 | $134,000 | -65.1% | 53,971 | +104.9% | 0.00% | -100.0% |
| Q3 2021 | $384,000 | +4.1% | 26,340 | -16.8% | 0.00% | 0.0% |
| Q2 2021 | $369,000 | -22.0% | 31,656 | -16.4% | 0.00% | -33.3% |
| Q4 2020 | $473,000 | +23550.0% | 37,846 | +37746.0% | 0.00% | – |
| Q4 2019 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,545,573 | $3,447,000 | 1.85% |
| P.A.W. CAPITAL CORP | 200,000 | $446,000 | 0.67% |
| SANDERS MORRIS HARRIS LLC | 848,048 | $2,020,000 | 0.50% |
| Monaco Asset Management SAM | 458,851 | $1,023,000 | 0.39% |
| Bleichroeder LP | 555,000 | $1,238,000 | 0.26% |
| APOGEM CAPITAL LLC | 110,614 | $247,000 | 0.25% |
| Slate Path Capital LP | 1,483,619 | $3,308,000 | 0.22% |
| Voss Capital, LLC | 200,000 | $446,000 | 0.13% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,067,000 | 0.11% |
| CARLSON CAPITAL L P | 535,000 | $1,193,000 | 0.09% |